GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Current Deferred Taxes Liabilities

Curocell (XKRX:372320) Current Deferred Taxes Liabilities : ₩0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Curocell's current deferred tax liabilities for the quarter that ended in Jun. 2023 was ₩0.00 Mil.

Curocell Current Deferred Taxes Liabilities Historical Data

The historical data trend for Curocell's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Current Deferred Taxes Liabilities Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Taxes Liabilities
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Current Deferred Taxes Liabilities - - - -

Curocell Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Curocell's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines